1372859-16-9

Basic information

• Product Name: Deoxynivalenol 15-Glucuronide
• Synonyms: Deoxynivalenol 15-Glucuronide
• CAS NO: 1372859-16-9
• Molecular Formula: C21H28O12
• Molecular Weight: 472.43982
• Product Categories: Chiral Reagents, Inhibitors, Glucuronides, Mutagenesis Research Chemicals, Pharmaceuticals, Intermediates & Fine Chemicals
• Mol File: 1372859-16-9.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 800.1±65.0 °C(Predicted)
• Appearance: /
• Density: 1.67±0.1 g/cm3(Predicted)
• PKA: 2.82±0.70(Predicted)
• CAS DataBase Reference: Deoxynivalenol 15-Glucuronide(CAS DataBase Reference)
• NIST Chemistry Reference: Deoxynivalenol 15-Glucuronide(1372859-16-9)
• EPA Substance Registry System: Deoxynivalenol 15-Glucuronide(1372859-16-9)

Safety Data

• Hazardous Substances Data: 1372859-16-9(Hazardous Substances Data)

Usage

Description

Deoxynivalenol 15-glucuronide is a metabolite of deoxynivalenol (DON), a type of mycotoxin produced by certain Fusarium species of fungi. It is formed when the body metabolizes deoxynivalenol, and its presence can be used to indicate exposure to this toxin.

Uses

Used in Food Safety and Toxicology:
Deoxynivalenol 15-glucuronide is used as a biomarker for [detecting exposure to] dietary deoxynivalenol (D243900), a tricothecene myotoxin. This application is important because it helps to monitor and assess the potential health risks associated with the consumption of contaminated food products, ensuring the safety and quality of the food supply.
Used in Agricultural and Environmental Research:
Deoxynivalenol 15-glucuronide can also be used as a research tool in the fields of agriculture and environmental science. It can help scientists study the prevalence and impact of mycotoxins in crops and the environment, as well as develop strategies for mitigating their effects on human and animal health.
Used in Diagnostics and Clinical Testing:
In the medical field, Deoxynivalenol 15-glucuronide can be used as a diagnostic marker for [assessing exposure to] mycotoxins in patients presenting with symptoms related to mycotoxin poisoning. This can aid in the early detection and treatment of mycotoxin-related health issues, improving patient outcomes and reducing the overall burden of disease.